There is a contemporary role for RMB in the era of SRM as the incorporation of molecular profiling of tissue from RMB would augment our ability to risk stratify SRMs on an individual patient basis and adopt management accordingly. However, clinical judgement is paramount as there remains an unpredictable non-negligible risk of disease progression and metastasis whilst on surveillance.
Academic Department of Urology and of Radiology of La Pitié-Salpétrière Tenon, University Paris VI, Paris, France.
BJU Int. 2012 Mar;109(6):867-72
© Galenicom 1999-2013